The one sector of the stock market that is cheap with upside today
Karen Firestone of Aureus Asset Management breaks down the case for biopharmaceuticals. Source link
Read More
Bristol-Myers Squibb Co
Stocks making the biggest moves midday: Wynn Resorts, Rocket Lab USA, Cassava Sciences and more
These are some of the stocks posting the largest moves in midday trading. Source link
Read More
FDA approves Bristol Myers Squibb’s schizophrenia drug, the first new type of treatment in decades
The twice-daily pill, Cobenfy, is a badly needed new treatment option for the nearly 3 million adults in the U.S.
Read More
Veteran investor Dietze names the sectors — and stocks — he likes right now
Peapack Wealth Management's David Dietze continues to see opportunities in the market and revealed what he is betting on right
Read More
Here’s where to invest $1 million, according to the pros
CNBC Pro asked veteran investors how they would allocate their portfolios with as much as $1 million. They shared tips
Read More
Drugmakers bet billions that targeted radiation could become the next cancer breakthrough
Bristol Myers Squibb, AstraZeneca, Eli Lilly and other drug companies have invested some $10 billion on promising cancer technology behind
Read More
The forgotten pharma stocks left in the dust by Eli-Lilly could be primed for a comeback
Katie Stockton breaks down the charts in Bristol-Myers, J&J and Pfizer. Source link
Read More
What’s next for the Biden administration’s Medicare drug price negotiations
The Medicare negotiations are a multi-round process that could produce more savings for taxpayers and seniors and put more pressure
Read More
Biden administration to release prices for first 10 drugs subject to landmark Medicare negotiations
It is a milestone in a controversial process that aims to make costly medications more affordable for older Americans but
Read More